Literature DB >> 7373056

Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

L M McManus, D J Hanahan, C A Demopoulos, R N Pinckard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373056

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  57 in total

1.  Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes.

Authors:  S Denault; M J April; J Stanková
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock.

Authors:  B Stein; E Pfenninger; A Grünert; J E Schmitz; M Hudde
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

5.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

6.  Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.

Authors:  L M McManus; R N Pinckard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

7.  Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).

Authors:  G Camussi; C Tetta; G Segoloni; M Chiara Deregibus; F Bussolino
Journal:  Agents Actions       Date:  1981-12

8.  Platelet involvement in rat paw edema induced by 2-methoxy-PAF.

Authors:  P M Silva; R S Cordeiro; M A Martins; M G Henriques; B B Vargaftig
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

9.  Protection of platelet-activating factor-induced acute renal failure by BN 52021.

Authors:  E Pirotzky; P Colliez; C Guilmard; J Schaeverbeke; J M Mencia-Huerta; P Braquet
Journal:  Br J Exp Pathol       Date:  1988-04

Review 10.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.